Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL.
Sep 2009 - Mol. Ther.:1525-0024 [PMID:19738604]
[Huang JH] [Zhang SN] [Choi KJ] [Choi IK] [Kim JH] [Lee M] [Kim H] [Yun CO]

Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Feb 2009 - Immunol. Lett.; 122(1):1879-0542 [PMID:19135479]
[Kim JH] [Kang TH] [Noh KH] [Bae HC] [Kim SH] [Yoo YD] [Seong SY] [Kim TW]

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.
Nov 2007 - Clin. Immunol.; 125(3):1521-6616 [PMID:17916447]
[Kim JH] [Lee Y] [Bae YS] [Kim WS] [Kim K] [Im HY] [Kang WK] [Park K] [Choi HY] [Lee HM] [Baek SY] [Lee H] [Doh H] [Kim BM] [Kim CY] [Jeon C] [Jung CW]

DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
Aug 2007 - Cancer Immunol. Immunother.; 56(11):0340-7004 [PMID:17443323]
[Lim DS] [Kim JH] [Lee DS] [Yoon CH] [Bae YS]